Johnson KD, Smith ST, Pouliot JD, Miller LN. Comparison of pharmacist- and provider-managed lithium in an inpatient medical center: a 6-month review. J Am Pharm Assoc (2003). 2021;61(5):e103-e107. doi:10.1016/j.japh.2021.06.014
Johnson KD, Miller LN, Pouliot JD, Martin PR. Retrospective analysis of oxcarbazepine in pregnant women with substance use disorders: Focus on safety. J Pharm Pract. 2019. doi: 10.1177/0897190019850700
Fuchs PA, Isaacs DA, Schiff M, Miller L, Stovall J. Severe extrapyramidal symptoms in a patient with Niemann-Pick type C disease after a long-acting injection of risperidone. J Clin Psychopharmacol. 2019;39(6):677-678. doi:10.1097/jcp.0000000000001119
Miller LN, Mercer SL. Drugs of abuse and addiction: An integrated approach to teaching. Curr Pharm Teach Learn. 2017;9(3):405-414. doi: 10.1016/j.cptl.2017.01.003
Mayberry KM, Miller LN. Incidence of self-reported depression among pharmacy residents in Tennessee. Am J Pharm Educ. 2017;81(8):5960. doi: 10.5688/ajpe5960
Boswell JC, Lee JT, Burghart SM, Scholtes K, Miller LN. Medication reconciliation improvement in a private psychiatric inpatient hospital. Mental Health Clinician. 2015;5(1):35-39. doi: 10.9740/mhc.2015.01.035